1. US Department of Health and Human Services, Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), Tripartite International Conference of Harmonization (ICH): Guidance for Industry, Q8 Pharmaceutical Development, 2006.
2. US Department of Health and Human Services, Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), Tripartite International Conference of Harmonization (ICH): Guidance for Industry, Q9 Quality Risk Management, 2005.
3. US Department of Health and Human Services, Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), Tripartite International Conference of Harmonization (ICH): Guidance for Industry, Q10 Pharmaceutical Quality System, 2008.
4. The use of surface-energy values to predict optimum binder selection for granulations;Zajic;International Journal of Pharmaceutics,1990
5. Polar non-polar interactions in the granulation of organic substrates with polymer binding-agents;Rowe;International Journal of Pharmaceutics,1989